Uridine Monophosphate

Supplements · Nootropics · Supplement, Typed Supps

A natural cell-building compound your body already produces itself, sold as a brain supplement — though the most interesting human results come from a related, differently-formulated compound tested at much higher doses in a small psychiatric study.

Stage by stage

Intake (Capsule or powder): Taken orally.
Absorption (Gut): Absorbed with known bioavailability limitations for the free form.
Bloodstream (Circulates): Travels to tissues including the brain.
Brain (Phospholipid/membrane synthesis): Proposed to support cell membrane and mitochondrial function, shown mainly in animal studies.

What the evidence supports

Reducing depressive symptoms in bipolar depression, as the prodrug triacetyluridine — limited evidence. A small, open-label proof-of-concept trial in bipolar depression patients using triacetyluridine (up to 18g/day for 6 weeks) found meaningful reductions in depression rating scale scores without triggering mania, and improved a marker of brain cellular energy metabolism. This is real human data, but it’s a small, open-label (not placebo-controlled), single trial — not a confirmed treatment.
Uridine monophosphate itself, taken orally as a standalone dietary supplement, replicating these effects — insufficient evidence. Most of the supportive clinical human data uses triacetyluridine, a different, more bioavailable prodrug, or intravenous/animal administration — not oral uridine monophosphate itself, which has much thinner direct human trial support and known oral bioavailability limitations.
Supporting brain phospholipid synthesis and neurite outgrowth — insufficient evidence. This mechanism and related cognitive claims are supported almost entirely by animal studies (rats, gerbils) showing increased brain CDP-choline and phospholipid precursor levels; direct human cognitive outcome data specific to standalone uridine monophosphate is lacking.

Typical dose

Supplement products commonly suggest a few hundred milligrams to low grams daily, but this doesn’t match the dosing used in the one meaningful human trial (triacetyluridine, a different compound, up to 18g/day).

Upper limit: No established UL for uridine monophosphate.

Timing

No validated timing guidance exists for standalone oral uridine monophosphate.

Time to effect

Unclear: The one relevant human trial used a different, higher-dose prodrug (triacetyluridine) in a psychiatric population, so no timeline is established for the consumer supplement form.

Common myth

“Uridine monophosphate supplements are proven to boost mood and brain function in people, just like the research shows.” In reality: The most notable human data involves triacetyluridine, a different and far more bioavailable prodrug dosed at levels dramatically higher than typical consumer UMP supplements, tested in a small, open-label trial in bipolar depression patients — not standalone oral uridine monophosphate in the general population.